Nanoparticle therapeutics for prostate cancer treatment

Maturitas

Volumn 73, Issue 1, 2012, Pages 27-32

  Sanna, Vanna ^a   Sechi, Mario ^a,b  

^a Porto Conte Ricerche Srl   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Diagnosis; Nanoparticles; Prostate cancer; Targeted nanoparticles; Theranostic

Indexed keywords

BIND 014; BOMBESIN CONJUGATED HISTIDINE GLYCOL CHITOSAN; CARBON NANOTUBE; CATECHIN; CREMOPHOR; CURCUMIN; DOCETAXEL; EPIGALLOCATECHIN GALLATE; GOLD NANOPARTICLE; LIPOSOME; LYMPHOTROPIC SUPERPARAMAGNETIC NANOPARTICLE; MACROGOL; MAGNETIC NANOPARTICLE; NANOBUBBLE; NANOPARTICLE; PACLITAXEL; PENTAPEPTIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; POLYSACCHARIDE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIOPHYSICS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED RELEASE FORMULATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; HYPERSENSITIVITY REACTION; NANOEMULSION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PROSTATE CANCER; REVIEW; SOLID TUMOR; TEA; VASCULARIZATION;

ANIMALS; HUMANS; MALE; NANOMEDICINE; NANOPARTICLES; PROSTATIC NEOPLASMS;

EID: 84865017928     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.01.016     Document Type: Review

References (50)

1. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 5 2005 161 171 (Pubitemid 40314948)
2. M.D. Wang, D.M. Shin, J.W. Simons, and S. Nie Nanotechnology for targeted cancer therapy Expert Rev Anticancer Ther 7 2007 833 837 (Pubitemid 47007989)
3. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 2 2007 751 760 (Pubitemid 350223348)
4. M.E. Davis, Z.G. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat Rev Drug Discov 7 2008 771 782
5. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv Drug Deliv Rev 60 2008 1615 1626
6. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
7. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat Rev Drug Discov 9 2010 615 627
8. D.J. Bharali, and S.A. Mousa Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise Pharmacol Ther 128 2010 324 335
9. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol Pharmacol 5 2008 505 515
10. K.H. Bae, H.J. Chung, and T.G. Park Nanomaterials for cancer therapy and imaging Mol Cells 31 2011 295 302
11. http://www.cancer.gov/cancertopics/types/prostate.
12. I.A. Siddiqui, and H. Mukhtar Nanochemoprevention by bioactive food components: a perspective Pharm Res 27 2010 1054 1060
13. H.B. Nair, B. Sung, V.R. Yadav, R. Kannappan, M.M. Chaturvedi, and B.B. Aggarwal Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer Biochem Pharmacol 80 2010 1833 1843
14. G. Leonarduzzi, G. Testa, B. Sottero, P. Gamba, and G. Poli Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids Curr Med Chem 17 2010 74 95
15. C.S. Yang, X. Wang, G. Lu, and S.C. Picinich Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nat Rev Cancer 9 2009 429 439
16. J.J. Johnson, H.H. Bailey, and H. Mukhtar Green tea polyphenols for prostate cancer chemoprevention: a translational perspective Phytomedicine 17 2010 3 13
17. S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Res 66 2006 1234 1240 (Pubitemid 43165995)
18. M. Brausi, F. Rizzi, and S. Bettuzzi Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update Eur Urol 54 2008 472 473
19. I.A. Siddiqui, V.M. Adhami, and D.J. Bharali Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate Cancer Res 69 2009 1712 1716
20. V. Sanna, G. Pintus, and A.M. Roggio Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells J Med Chem 54 2011 1321 1332
21. M.I. Davis, M.J. Bennett, L.M. Thomas, and P.J. Bjorkman Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase Proc Natl Acad Sci U S A 102 2005 5981 5986 (Pubitemid 40594241)
22. S. Rocha, R. Generalov, C. Pereira Mdo, I. Peres, P. Juzenas, and M.A. Coelho Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention Nanomedicine 6 2011 79 87
23. O.C. Farokhzad, J. Cheng, and B.A. Teply Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc Natl Acad Sci U S A 103 2006 6315 6320
24. F. Gu, R. Langer, and O.C. Farokhzad Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery Methods Mol Biol 544 2009 589 598
25. F. Gu, L. Zhang, and B.A. Teply Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc Natl Acad Sci U S A 105 2008 2586 2591 (Pubitemid 351520557)
26. F. Alexis, E.M. Pridgen, R. Langer, and O.C. Farokhzad Nanoparticle technologies for cancer therapy Handb Exp Pharmacol 197 2010 55 86
27. R.L. Thangapazham, A. Puri, S. Tele, R. Blumenthal, and R.K. Maheshwari Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells Int J Oncol 32 2008 1119 1123
28. V. Sanna, A.M. Roggio, and A.M. Posadino Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co- glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies Nanoscale Res Lett 6 2011 260
29. W. Peng, D.G. Anderson, Y. Bao, R.F. Padera Jr., R. Langer, and J.A. Sawicki Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors Prostate 67 2007 855 862 (Pubitemid 46828939)
30. D. Goldstein, O. Gofrit, A. Nyska, and S. Benita Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer Cancer Res 67 2007 269 275 (Pubitemid 46142784)
31. S. Krishnan, P. Diagaradjane, and S.H. Cho Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy Int J Hyperthermia 26 2010 775 789
32. J.G. Walter, S. Petersen, F. Stahl, T. Scheper, and S. Barcikowski Laser ablation-based one-step generation and bio-functionalization of gold nanoparticles conjugated with aptamers J Nanobiotechnol 8 2010 21
33. BIND Biosciences initiates Phase 1 clinical study of BIND-014. Available from: http://www.bindbio.com/content/pages/news/news-detail.jsp/q/news-id/55.
34. J. Shi, Z. Xiao, N. Kamaly, and O.C. Farokhzad Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation Acc Chem Res 44 2011 1123 1134
35. C.S. Thaxton, R. Elghanian, and A.D. Thomas Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy Proc Natl Acad Sci U S A 106 2009 18437 18442
36. J.A. Viator, S. Gupta, and B.S. Goldschmidt Gold nanoparticle mediated detection of prostate cancer cells using photoacoustic flowmetry with optical reflectance J Biomed Nanotechnol 6 2010 187 191
37. M. Johannsen, U. Gneveckow, and B. Thiesen Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution Eur Urol 52 2007 1653 1661
38. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499 (Pubitemid 36706536)
39. Q. Huo, J. Colon, and A. Cordero A facile nanoparticle immunoassay for cancer biomarker discovery J Nanobiotechnology 9 2011 20
40. C.M. Lee, H.J. Jeong, and S.J. Cheong Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin Pharm Res 27 2010 712 721
41. S.M. Janib, A.S. Moses, and J.A. MacKay Imaging and drug delivery using theranostic nanoparticles Adv Drug Deliv Rev 62 2010 1052 1063
42. M.E. Gindy, and R.K. Prud'homme Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy Expert Opin Drug Deliv 6 2009 865 878
43. A.Z. Wang, V. Bagalkot, and C.C. Vasilliou Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy ChemMedChem 3 2008 1311 1315
44. V. Bagalkot, L. Zhang, and E. Levy-Nissenbaum Quantum dot - aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on Bi-fluorescence resonance energy transfer Nano Lett 7 2007 3065 3070 (Pubitemid 350132931)
45. D. Kim, Y.Y. Jeong, and S. Jon A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer ACS Nano 4 2010 3689 3696
46. L. Agemy, K.N. Sugahara, and V.R. Kotamraju Nanoparticle-induced vascular blockade in human prostate cancer Blood 116 2010 2847 2856
47. E.Y. Lukianova-Hleb, A.O. Oginsky, and A.P. Samaniego Tunable plasmonic nanoprobes for theranostics of prostate cancer Theranostics 1 2011 3 17
48. K. Riehemann, S.W. Schneider, T.A. Luger, B. Godin, M. Ferrari, and H. Fuchs Nanomedicine - challenge and perspectives Angew Chem Int Ed Engl 48 2009 872 897
49. B. Godin, E. Tasciotti, X. Liu, R.E. Serda, and M. Ferrari Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics Acc Chem Res 44 2011 979 989
50. B.S. Zolnik, A. González-Fernández, N. Sadrieh, and M.A. Dobrovolskaia Nanoparticles and the immune system Endocrinology 151 2010 458 465